• About Us
  • Who Are We
  • Work With Us
Monday, January 30, 2023
No Result
View All Result
NEWSLETTER
The Globe Post
39 °f
New York
44 ° Fri
46 ° Sat
40 ° Sun
41 ° Mon
No Result
View All Result
The Globe Post
No Result
View All Result
Home Featured

Russia Reports Success in COVID-19 Vaccine Trial

Delaney Murray by Delaney Murray
07/15/20
in Featured, World
Researchers rush to find a COVID-19 vaccines as global cases continue to rise.

The global race for a vaccine continues as global cases continue to climb. Photo: AFP

Share on FacebookShare on Twitter

As the global race to find a COVID-19 vaccine continues, Russia believes it has had a breakthrough.

The country’s ministry of defense announced on Wednesday that participants in a vaccine trial had been discharged from the hospital after receiving a vaccine candidate. They had been undergoing daily examinations for 28 days.

The defense ministry said the participants left the hospital without “serious adverse events, health complaints, complications, or adverse reactions were not recorded.”

Clinical trials of Russian anti-#Covid_19 vaccine have been successfully completed in Sechenov First Moscow State Medical University. The tests showed vaccine’s full safety. The volunteers are to be dismissed from hospital on 20 July pic.twitter.com/37rynkhle8

— Russia in RSA 🇷🇺 (@EmbassyofRussia) July 13, 2020

Russia’s defense ministry is developing the vaccine together with the Moscow-based Gamaleya Institute. The trial included both military personnel and civilian volunteers. A second trial has begun and is scheduled to finish by the end of July.

The development advances as Russia reports nearly 750,000 infections and more than 11,000 deaths. The WHO said the country is experiencing cases that are “clustered in time, geographic location and/or by common exposures.”

Global Vaccine Race

As global coronavirus cases continue to rise, countries are racing to be the first to discover a vaccine.

In the United States, the country with the highest number of both cases and deaths, the pharmaceutical company Moderna has a vaccine candidate that just entered phase 3 of its clinical trial. In phase 3, the second-last phase, clinical trials are “conducted on larger populations and in different regions and countries” according to the WHO. The tests have been showing successful early results.

In Australia, a vaccine developed by the University of Queensland entered phase 1 of human trials in which developers test dosage range and side effects. Preliminary results are to be recorded three months after the vaccine’s initial dose.

The United Kingdom has two current vaccines that are being developed. One is developed by the University of Oxford and has entered phase 3 of clinical trials. Imperial College London is also working on a vaccine, which enters phase 1 of clinical trials.

In China, the biopharmaceutical company Sinovac is developing a vaccine that has just entered phase 3 of clinical trials and received approval from the Brazilian National Regulatory Agency to conduct a trial in Brazil.

Global infections passed 13.4 million on Wednesday. While making a vaccine normally takes years of testing, scientists hope to develop a coronavirus vaccine within 12 to 18 months.

ShareTweet
Delaney Murray

Delaney Murray

Follow her @DelaneyMurray8

Related Posts

Pfizer logo and vaccines
World

Pfizer to Sell More Drugs at Cost to Poor Nations

by Staff Writer
January 18, 2023
Soledar lies 15 kilometres (nine miles) from the city of Bakhmut, which Russia has been trying to seize for months
World

Fate of Ukraine’s Soledar Unclear as Wagner Claims Control

by Staff Writer
January 11, 2023
A woman undergoing COVID test in China
Featured

Soaring Covid Cases Shine Light on China’s Healthcare Gap

by Staff Writer
January 11, 2023
Russian passports
World

EU Won’t Recognize Russian Passports From Occupied Ukraine

by Staff Writer
November 10, 2022
Russia Today
World

Russian TV Host Apologizes for Calls to Burn Ukrainian Children

by Staff Writer
October 24, 2022
Arne Schoenbohm
World

German Cybersecurity Chief Sacked Over Alleged Russia Ties

by Staff Writer
October 18, 2022
Next Post
Protestor in Puerto Rico, where the nation angry over corruption and the release of insulting text chats

Can’t We Just Sell the World’s Oldest Colony and Solve Puerto Rico’s Political Status?

Elyes Fakhfakh resigns from Tunisia post no-confidence motion

Tunisia Risks Fresh Political Deadlock as PM Resigns

Please login to join discussion

Recommended

Israeli security forces in Jerusalem

Palestinian Gunman Kills 7 in East Jerusalem Synagogue Attack

January 30, 2023
The Doomsday Clock reads 100 seconds to midnight, a decision made by The Bulletin of Atomic Scientists, during an announcement at the National Press Club in Washington, DC on January 23, 2020

‘Doomsday Clock’ Moves Closest Ever to Midnight

January 25, 2023
Police work near the scene of a mass shooting in Monterey Park, California

California Lunar New Year Mass Shooter Dead, Motive Unclear: Police

January 23, 2023
New Zealand Prime Minister Jacinda Ardern

Race on To Replace Ardern as New Zealand Prime Minister

January 20, 2023
Pfizer logo and vaccines

Pfizer to Sell More Drugs at Cost to Poor Nations

January 18, 2023
Rescuers inspect the wreckage at the site of a Yeti Airlines plane crash in Pokhara, Nepal

At Least 67 Killed in Nepal Plane Crash

January 16, 2023

Opinion

George Santos from the 3rd Congressional district of New York

George Santos for Speaker!

January 16, 2023
Commuters waiting for buses in Metro Manila. Philippines

Eight Billion and Counting…

November 29, 2022
Mahsa Amini protests

Imagining a Free Iran

October 24, 2022
Vladimir Putin

How 18th Century International Law Clarifies the Situation in Ukraine

September 29, 2022
Vladimir Putin

Falling for Putin

September 15, 2022
US President Donald Trump

Donald Trump Thanks You for Your Sacrifice

August 17, 2022
Facebook Twitter

Newsletter

Do you like our reporting?
SUBSCRIBE

About Us

The Globe Post

The Globe Post is part of Globe Post Media, a U.S. digital news organization that is publishing the world's best targeted news sites.

submit oped

© 2018 The Globe Post

No Result
View All Result
  • National
  • World
  • Business
  • Interviews
  • Lifestyle
  • Democracy at Risk
    • Media Freedom
  • Opinion
    • Editorials
    • Columns
    • Book Reviews
    • Stage
  • Submit Op-ed

© 2018 The Globe Post